Annette M. Silvia

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

Robert S. Wallis, Rodney Dawson, Sven O. Friedrich et al. · PLoS ONE · 2014 · 166 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

Robert S. Wallis, Wesley Jakubiec, Vikas Kumar et al. · Antimicrobial Agents and Chemotherapy · 2010 · 128 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacokinetics and Whole‐Blood Bactericidal Activity against<i>Mycobacterium tuberculosis</i>of Single Doses of PNU‐100480 in Healthy Volunteers

Robert S. Wallis, Wesley Jakubiec, Vikas Kumar et al. · The Journal of Infectious Diseases · 2010 · 102 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide

Robert S. Wallis, Wesley Jakubiec, Mark J. Mitton‐Fry et al. · PLoS ONE · 2012 · 74 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition

William P. Esler, Gregory J. Tesz, Marc K. Hellerstein et al. · Science Translational Medicine · 2019 · 63 citations

Life Sciences, Biochemistry, Dermatology +14